Table 4.

Situations in cancer care better and worse suited to telemedicine use, as reported from staff and provider interviews.

Category	Better for telemedicine	Worse for telemedicine
Cancer type	Less aggressive Generally stable over time (eg, hematological cancers) Monitoring or treatment largely based on labs or imaging scans	Rapidly progressing or unstable Need to assess tolerance to new therapy Physical exam important to assess (eg, breast, GIa or GUb, and head or neck cancer)
Visit type	Routine interval monitoring between treatments Patient or family education (eg, chemo teaches) Survivorship follow-up visits	Patient already on site for treatment visit or scan ”Decision point“ for changes (eg, hospice transition or continuation of therapy)

^aGI: gastrointestinal.

^bGU: genitourinary.